103441-72-1 Usage
Description
Methyl 2-vinylnicotinate is a chemical compound belonging to the class of vinylnicotinates. It is an ester derivative of 2-vinylnicotinic acid with a methyl group attached to the nitrogen atom. Methyl 2-vinylnicotinate is known for its potential biological activity and is recognized for its antioxidant and anti-inflammatory properties, which make it a valuable candidate in the development of drugs for various conditions.
Uses
Used in Pharmaceutical Synthesis:
Methyl 2-vinylnicotinate is used as an intermediate in the synthesis of pharmaceuticals for its potential biological activity. Its antioxidant and anti-inflammatory properties contribute to the development of drugs aimed at treating various conditions.
Used in Agrochemical Synthesis:
In the agrochemical industry, Methyl 2-vinylnicotinate is utilized as a precursor in the synthesis of agrochemicals, leveraging its biological activity to create compounds that can be used in agricultural applications.
Used in Organic Synthesis:
Methyl 2-vinylnicotinate is employed as a reagent in organic synthesis, where its unique structure and properties allow for the creation of new organic compounds for various applications.
Used in Materials Science:
In the field of materials science, Methyl 2-vinylnicotinate is used for the development of new materials, potentially contributing to advancements in areas such as polymer science and material engineering due to its versatile chemical structure.
Check Digit Verification of cas no
The CAS Registry Mumber 103441-72-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,4,4 and 1 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 103441-72:
(8*1)+(7*0)+(6*3)+(5*4)+(4*4)+(3*1)+(2*7)+(1*2)=81
81 % 10 = 1
So 103441-72-1 is a valid CAS Registry Number.
103441-72-1Relevant articles and documents
MODULATORS OF HEMOGLOBIN
-
Paragraph 0212-0213; 0225-0226, (2020/06/08)
The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.
Ready access to 7,8-dihydro- and 1,2,3,4-tetrahydro-1,6-naphthyridine-5(6H) -ones from simple pyridine precursors
Showalter, H. D. Hollis
, p. 1311 - 1317 (2007/10/03)
Short pathways are described for the synthesis of a representative example of each of the 7,8-dihydro- and 1,2,3,4-tetrahydro-1,6-naphthyridine-5(6H)-one ring systems from simple pyridine precursors. An attempted synthesis of the related 4,6-dihydro-1,6-naphthyridin-5(1H)-one ring system from a common intermediate was unsuccessful.
